课题基金 / 基金详情

Information Technology for Human Subjects Protection

Information Technology for Human Subjects Protection
人类受试者保护的信息技术
批准号:
6591413
负责人:
SHLOMO MELMED
金额:
$10.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-01 至 2003-08-31

项目摘要

项目成果

SHLOMO MELMED的其他基金

相似基金

相关文献

中文摘要
翻译
本提案是为了响应卫生与公众服务部的一项倡议而提交的,该倡议旨在加强对接受NIH大量支持的机构的人体受试者研究的监督。此应用程序建议创建一个信息系统基础设施的基础,使Cedars-Sinai医学中心(CSMC)能够不断加强对人体受试者研究的监督。CSMC是最大的私人非营利组织
英文摘要
This proposal is submitted in response to an initiative of the Department of Health and Human Services to strengthen oversight of human subject research at institutions that receive substantial NIH support. This application proposes to create the foundation of an information systems infrastructure that will enable Cedars-Sinai Medical Center (CSMC) to continuously enhance the oversight of human subject research. CSMC is the largest private non-profit hospital west of the Mississippi River. There currently are more than 500 active human subject research protocols. In 2000, 53.3% of research awards at CSMC - 20.3 million dollars - were funded by federal agencies. The goal of this project is to develop an online submission, reporting, tracking, and review system that will strengthen the human subject protection program at CSMC. The Electronic Human Subject Protection Program (eHSPP) aims to: (1) strengthen the institutional education program for the safe and ethical conduct of clinical research; (2) increase the level of IRB oversight of, and monitoring for, the safe conduct of human subject research; (3) enhance the quality and efficiency of IRB reviews; and (4) improve system-wide compliance with regulations and ethical principles governing the conduct of human subject research through improved coordination between multiple institutional research review and oversight entities. The eHSPP will include online submission, tracking, and review functionality, as well as extensive educational help text and reference links. The eHSPP also will allow for robust information management and reporting capabilities. As each module of the eHSPP is brought online, as well as upon implementation of the completed eHSPP, it will be evaluated by monitoring quality and efficiency indicators as well as through the administration of pre/post user surveys. More extensive outcome evaluations and system modifications will be conducted on a continuous as needed basis subsequent to the grant period.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ph 2 Multicenter study of seliciclib for Cushing Disease IND 120,848 (10/10/2017)
  • 批准号:
    10003845
  • 项目类别:
  • 资助金额:
    $46.78万
  • 财政年份:
    2018
  • 负责人:
    SHLOMO MELMED
  • 依托单位:
Mechanisms for GH action on epithelial cells
  • 批准号:
    10578571
  • 项目类别:
  • 资助金额:
    $36.74万
  • 财政年份:
    2018
  • 负责人:
    SHLOMO MELMED
  • 依托单位:
Mechanisms for GH action on epithelial cells
  • 批准号:
    9893867
  • 项目类别:
  • 资助金额:
    $38.25万
  • 财政年份:
    2018
  • 负责人:
    SHLOMO MELMED
  • 依托单位:
Treatment of pituitary Cushing disease with a selective CDK inhibitor, R-roscovit
  • 批准号:
    8773516
  • 项目类别:
  • 资助金额:
    $23.44万
  • 财政年份:
    2014
  • 负责人:
    SHLOMO MELMED
  • 依托单位:
海外基金